Forte Steve is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Steve Forte is the executive vice president and chief financial officer of Repare Therapeutics Inc., a publicly traded precision oncology company focused on synthetic lethality therapies. As of the most recent SEC filing dated 2026-01-29, he held the CFO role with no reported stock purchases or sales in that filing. He leads the company’s financial operations and capital strategy.
Role
Insider
Notability
45/100
Board memberships
Repare Therapeutics Inc.
Awards & honors
Serves as CFO of a clinical-stage biotech company focusing on precision oncology.
Oversees financial reporting, budgeting, and capital allocation for Repare Therapeutics.
Supports investor relations and strategic financial communications.
Steve Forte is the executive vice president and chief financial officer of Repare Therapeutics Inc., a publicly traded precision oncology company focused on synthetic lethality therapies. As of the most recent SEC filing dated 2026-01-29, he held the CFO role with no reported stock purchases or sales in that filing. He leads the company’s financial operations and capital strate…
Where can I see all of Forte Steve's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
